Real-time enrollment status for this pca clinical trial
Current Status
Recruiting
Checked: July 23, 2026 at 11:00 PM UTC
| NCT Number | NCT07052214 |
| Recruiting Status | Recruiting |
| Condition | PCA |
| Phase | PHASE3 |
| Target Enrollment | 338 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Telix Pharmaceuticals (Innovations) Pty Limited |
| Last Updated on CT.gov | July 23, 2026 (23 hours ago) |
As of July 23, 2026: Clinical trial NCT07052214 is currently recruiting participants. This phase3 study for pca is actively seeking new participants at 16 locations across the United States. The study is sponsored by Telix Pharmaceuticals (Innovations) Pty Limited. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07052214 is actively recruiting participants as of July 23, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07052214 was last updated 23 hours ago (July 23, 2026). HelloStudys verifies this status automatically.